STK11 and lymphoma: Our data suggested that the regulation of the mevalonate pathway by Lkb1 in Tregs heavily influences lipid metabolism and is a critical mechanism for anti-tumor immunity, suggesting that targeting it may be a novel potential therapy strategy for lymphoma.